Treatment With Valoctocogene Roxaparvovec in a Patient With Severe Hemophilia A Led to Sustained Normal FVIII Levels.
Haemophilia : the official journal of the World Federation of Hemophilia
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationFrontiers in immunology
View this publicationEuropean radiology
View this publicationViruses
View this publicationNature aging
View this publicationInternational journal of cancer
View this publicationJournal of bacteriology
View this publicationExpert review of hematology
View this publicationCellular immunology
View this publicationClinical drug investigation
View this publication